Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mustafa Raoof

Showing results (121-130 of 163) with videos related to

Pageof 17
Sort By:
Annals of Surgery|June 26, 2025
Comparison of Cancer Care Delivery and Outcomes in Medicare Advantage with Traditional MedicareMuhammad Talha Waheed, Kevin M Sullivan, Matthew Hernandez, et al.
Annals of Surgery|August 26, 2025
Upfront Colectomy vs. Initial Appendectomy followed by Completion Colectomy for Appendiceal Cancer: A Comparison of OutcomesMuhammad Talha Waheed, Ibrahim Malik, Philip H G Ituarte, et al.
Annals of Surgery|April 11, 2025
Randomized Controlled Trial - Perioperative Telemonitoring of Patient Generated Health Data in Gastrointestinal Oncologic (GI) Surgery: Assessing OutcomesKelly M Mahuron, Patricia Esslin, Virginia Sun, et al.
The Journal of Surgical Research|May 7, 2022
Is Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy Still Indicated in Patients With Extraperitoneal Disease?Eliza W Beal, J C Chen, Alex Kim, et al.
Frontiers in Oncology|January 24, 2025
Long term outcomes associated with the use of perioperative systemic chemotherapy on low grade appendiceal mucinous neoplasms with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapySamantha M Ruff, Gyulnara Kasumova, Manoj Palavalli, et al.
Pleura and Peritoneum|March 23, 2026
Multicenter dose de-escalation phase I trial of pressurized intraperitoneal aerosolized chemotherapy (PIPAC) nab-paclitaxel and cisplatin in combination with systemic nab-paclitaxel in recurrent ovarian cancer patients: trial in progressVinita Popat, Paul H Frankel, Nora H Ruel, et al.
World Journal of Surgery|April 28, 2025
Predicting Severe Postoperative Complications after CRS-HIPEC: An Externally Validated Machine-Learning ToolAmir Ashraf Ganjouei, Jane Wang, Christopher Yi, et al.
NPJ Precision Oncology|December 14, 2025
Divergent oncogenic signaling and immune microenvironment changes in low-grade serous ovarian cancer patients undergoing intraperitoneal chemotherapyIsaac Bishara, Patrick A Cosgrove, Sumana Majumdar, et al.
The Journal of Surgical Research|September 4, 2023
Prediction of Early Recurrence Following CRS/HIPEC in Patients With Disseminated Appendiceal CancerGopika SenthilKumar, Jennifer Merrill, Ugwuji N Maduekwe, et al.
Annals of Surgical Oncology|August 13, 2021
PIPAC for the Treatment of Gynecologic and Gastrointestinal Peritoneal Metastases: Technical and Logistic Considerations of a Phase 1 TrialMustafa Raoof, Gautam Malhotra, Adrian Kohut, et al.
Pageof 17

Showing results (121-130 of 163) with videos related to

Sort By:
Pageof 17
Annals of Surgery|June 26, 2025
Comparison of Cancer Care Delivery and Outcomes in Medicare Advantage with Traditional MedicareMuhammad Talha Waheed, Kevin M Sullivan, Matthew Hernandez, et al.
Annals of Surgery|August 26, 2025
Upfront Colectomy vs. Initial Appendectomy followed by Completion Colectomy for Appendiceal Cancer: A Comparison of OutcomesMuhammad Talha Waheed, Ibrahim Malik, Philip H G Ituarte, et al.
Annals of Surgery|April 11, 2025
Randomized Controlled Trial - Perioperative Telemonitoring of Patient Generated Health Data in Gastrointestinal Oncologic (GI) Surgery: Assessing OutcomesKelly M Mahuron, Patricia Esslin, Virginia Sun, et al.
The Journal of Surgical Research|May 7, 2022
Is Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy Still Indicated in Patients With Extraperitoneal Disease?Eliza W Beal, J C Chen, Alex Kim, et al.
Frontiers in Oncology|January 24, 2025
Long term outcomes associated with the use of perioperative systemic chemotherapy on low grade appendiceal mucinous neoplasms with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapySamantha M Ruff, Gyulnara Kasumova, Manoj Palavalli, et al.
Pleura and Peritoneum|March 23, 2026
Multicenter dose de-escalation phase I trial of pressurized intraperitoneal aerosolized chemotherapy (PIPAC) nab-paclitaxel and cisplatin in combination with systemic nab-paclitaxel in recurrent ovarian cancer patients: trial in progressVinita Popat, Paul H Frankel, Nora H Ruel, et al.
World Journal of Surgery|April 28, 2025
Predicting Severe Postoperative Complications after CRS-HIPEC: An Externally Validated Machine-Learning ToolAmir Ashraf Ganjouei, Jane Wang, Christopher Yi, et al.
NPJ Precision Oncology|December 14, 2025
Divergent oncogenic signaling and immune microenvironment changes in low-grade serous ovarian cancer patients undergoing intraperitoneal chemotherapyIsaac Bishara, Patrick A Cosgrove, Sumana Majumdar, et al.
The Journal of Surgical Research|September 4, 2023
Prediction of Early Recurrence Following CRS/HIPEC in Patients With Disseminated Appendiceal CancerGopika SenthilKumar, Jennifer Merrill, Ugwuji N Maduekwe, et al.
Annals of Surgical Oncology|August 13, 2021
PIPAC for the Treatment of Gynecologic and Gastrointestinal Peritoneal Metastases: Technical and Logistic Considerations of a Phase 1 TrialMustafa Raoof, Gautam Malhotra, Adrian Kohut, et al.
Pageof 17